Category: IPO

All News on IPO

IPO

Tong Ren Tang TCM Healthcare Group: Comprehensive TCM Services, Expansion Strategies, and Competitive Strengths in China

Minichart

March 28, 2026

Yiyang Tongrentang IPO: In-Depth Analysis, Valuation, and In...

Continue Reading 0

IPO

Epiworld International: Global Leader in SiC Epitaxial Wafers for EVs, Renewable Energy, and AI – Market Growth & Investment Insights

Minichart

March 28, 2026

Epiworld International Co., Ltd. IPO Analysis: Offer Highlig...

Continue Reading 0

IPO

AI AutoVision®: Revolutionizing Chromosome Karyotyping with Intelligent Medical Imaging Solutions

Minichart

March 28, 2026

Hangzhou Diagens Biotechnology Co., Ltd. IPO: Comprehensive ...

Continue Reading 0

IPO

Guangdong Huayan Robotics Co., Ltd. Global Offering: Hong Kong IPO Details, Application Process, and Key Dates (March 2026) 236

Minichart

March 28, 2026

Guangdong Huayan Robotics Co., Ltd. IPO Analysis – March 20,...

Continue Reading 0

IPO

Epiworld International Co., Ltd. (Stock Code: 2726) Announces HKEX Global Offering Details and IPO Application Timeline for 2026

Minichart

March 28, 2026

Epiworld International Co., Ltd. IPO Analysis – March 20, 20...

Continue Reading 0

IPO

Financial Analysis Report

Minichart

March 28, 2026

Beijing Tong Ren Tang Healthcare Investment Co., Ltd. IPO An...

Continue Reading 0

IPO

Hangzhou Diagens Biotechnology Co., Ltd. Hong Kong IPO: Key Dates, Offer Details & Application Guide 2026 2467

Minichart

March 28, 2026

Hangzhou Diagens Biotechnology Co., Ltd. IPO: Key Details, A...

Continue Reading 0

IPO

Epiworld International Co., Ltd. Hong Kong IPO: Global Offering Details, Application Process & Key Dates 2026

Minichart

March 21, 2026

Epiworld International Co., Ltd. IPO Analysis: Key Insights,...

Continue Reading 0

IPO

The Metals Royalty Company Inc. F-1 Filing: Direct Listing on Nasdaq, Business Overview, and Investor Insights 71081

Minichart

March 21, 2026

The Metals Royalty Company Inc. IPO Analysis – Investor Deep...

Continue Reading 0

IPO

Salspera’s Saltikva: Breakthrough Oral Immunotherapy for Pancreatic Cancer Shows Promising Results in Phase 2 Trials

Minichart

March 21, 2026

Salspera, Inc. IPO Analysis – March 4, 2026 Company Name...

Continue Reading 0